Biocompatibles facing $1.2 million payout to avoid lawsuit
This article was originally published in Clinica
Executive Summary
Biocompatibles International, a UK company poised to enter the US stent market, has quietly allocated £900,000 ($1.2 million) to settle a legal action from a disgruntled US company which failed to win the distribution business from Biocompatibles.